Health
New target for drug development could fill a major gap in depression treatment – News-Medical.net – Port Macquarie Online News
Vanderbilt researchers found that ketamine’s rapid antidepressant action is due to specific synaptic effects.
THE IDEAVanderbilt researchers found that ketamine’s rapid antidepressant action is due to specific synaptic effects. This represents a new target for drug development that could fill a major gap in care for depression.The research was led by Lisa Monteggia,……
Continue Reading
-
Noosa News18 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
General16 hours agoCrowe toasts talkback titan for platforming ‘voiceless’
-
Business19 hours agoSolid superannuation gains continue to roll in
-
Noosa News17 hours agoLyka Doggie Date Night at Moonlight Cinema